Metzger Michael A bought PYXS
March 24, 2026 · Form 4 insider transaction
Metzger Michael A bought 45,867 shares of Pyxis Oncology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
45,867
Price
$0.00
Total value
N/A
InsiderMetzger Michael A
RoleOfficer, Director
CompanyPyxis Oncology, Inc. (PYXS)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 24, 2026
Filing dateMarch 25, 2026
Shares owned after45,867
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.